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Interleukin (IL)-3, IL-5 and granulocyte-macrophage-colony-stimulating factor (GM-
CSF) are cytokines that affect the growth, survival and differentiation of many cells 
within the haematopoietic system. The functions of these factors are mediated by 
membrane bound receptor complexes that are composed of specific ligand binding 
subunits (α) and a common signal transducing subunit (hβc). Constitutively activated 
mutants of hβc have been previously identified that are able to confer factor-
independent signalling in a number of haematopoietic cell lines (including FDC-P1 and 
FDB-1). These activated mutants fall into two classes defined by the location of the 
mutation and their biochemical and leukaemogenic properties. In particular, the 
transmembrane mutant, V449E, causes an acute myeloid leukaemia in vivo, whereas the 
extracellular mutants (FI∆ or I374N) cause chronic myeloproliferative disorders.  
The work described in this thesis used the activated hβc mutants to uncover 
novel transcriptional events induced by the GM-CSF/IL-3/IL-5 receptor complex and to 
define pathways associated with proliferation and differentiation. Large-scale gene 
expression profiling techniques were used to investigate the genes involved in these 
biological processes in the murine myelomonocytic cell line FDC-P1, and the bi-potent 
FDB-1 myeloid cell line, which are responsive to IL-3 and GM-CSF.  
Membrane arrays were used to identify differences in gene expression between 
I374N and V449E expressing FDC-P1 cells. This technique revealed that the gene 
Ptpmt1 was differentially expressed between V449E and I374N, which was 
subsequently confirmed by Northern blotting. This finding suggested that the 
phosphatase encoded by Ptpmt1 may be involved in the different outcomes induced by 
these two hβc mutants. Northern analysis also revealed Ptpmt1, Nab1 and Ddx26b to be 
regulated in response to human GM-CSF in FDC-P1 cells expressing human GM-CSFα 
and hβc. 
A large-scale cDNA microarray experiment was also performed to identify 
genes that are selectively expressed during differentiation of FI∆ expressing FDB-1 
cells, compared to proliferating V449E expressing FDB-1 cells over 24 hours. A 
comprehensive analysis approach was adopted to examine the microarray data and 
identify differentially expressed genes. Among the genes displaying differential 
  ixexpression were Btg1, S100a9, Cd24, and Ltf found to be differentiation-associated and 
Bnip3,  Cd34,  Myc,  Nucleophosmin, and Nucleostemin found to be proliferation-
associated.  Hipk1,  Klf6,  Sp100, and Sfrs3 were also identified as potential 
transcriptional regulators during growth and differentiation. Northern analysis was used 
to confirm differences in expression for these 13 genes between FI∆ and V449E 
expressing FDB-1 cells. Eleven of the 13 genes examined were confirmed to be 
differentially expressed between FI∆ and V449E expressing FDB-1 cells over 24 hours. 
Furthermore, six genes (Btg1, Hipk1, Cd24, Cd34, Klf6 and Nucleostemin) examined 
over 72 hours revealed differences in gene expression at early (6-12 hours) and late (48-
72 hours) time points. Cell surface expression of CD24 protein was also shown to be 
induced upon FI∆ expression or GM-CSF induced differentiation of FDB-1 cells, 
consistent with elevated levels of Cd24 mRNA in FI∆ cells over time. Based on their 
confirmed gene expression differences seen on the microarrays and Northern analysis, 
four genes (Btg1,  Cd24,  Klf6 and Nucleostemin) were selected for over-expression 
analysis in FDC-P1 or FDB-1 cells, in order to gain insights into the function of these 
genes. Optimisation of the retroviral infection process was performed so that the role of 
these genes in proliferation and differentiation could be investigated in the FDB-1 
model. Such preliminary functional experiments in FDB-1 cells will enable 
prioritisation of the genes for further analysis of their function in primary cells. Thus, 
the work in this thesis describes the first use of microarrays to identify gene expression 
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Ac     acetate 
ALL   acute  lymphoblastic  leukaemia 
ALV    avian leukosis virus 
AMegL  Acute megakaryocytic leukaemia 
AML    acute myeloid leukaemia 
AMV    avian myeloblastosis virus  
ANOVA   analysis of variation 
(α-
32P)dATP alpha-labelled  2’-deoxyadenosine-5’-triphophate 
(α-
33P)dCTP alpha-labelled  2’-deoxycytosine-5’-triphophate 
APL     acute promyelocytic leukaemia 
ATRA   all-trans-retinoic acid 
B-CLL   B-cell chronic lymphocytic leukaemia 
B-stat    B-statistic 
βc     common β subunit 
bp     base pair(s) 
BSA    bovine serum albumin 
cAMP   adenosine 3’, 5’-cyclic monophosphate  
Cdk   Cyclin-dependent  kinases 
cDMEM  complete Dulbecco’s modified Eagle’s medium 
cDNA   deoxyribonucleic acid complementary to ribonucleic acid 
CFU-GM colony-forming  unit granulocyte-macrophage 
cIMDM  complete Iscove’s modified Dulbecco’s medium 
CIP    calf intestinal phosphatase 
CIS     common insertion site 
CLL   chronic  lymphoblastic  leukaemia 
CML     chronic myeloid leukaemia  
CMML  chronic myelomonocytic leukaemia 
CMP     common myeloid progenitor 
CNTF   ciliary neurotrophic factor 
cpm     counts per minute 
  xivcps     counts per second 
CRD   cytokine  receptor  domain 
CRM     cytokine receptor module 
Cyc A   Cyclophilin A 
DEPC    diethyl pyrocarbonate 
DMEM  Dulbecco’s modified Eagle’s medium 
DMSO   dimethyl sulfoxide 
DNA   deoxyribonucleic  acid 
dNTP    deoxynucleotide-triphosphate 
DTT     dithiothreitol 
EC   extracellular 
E.coli   Escherichia  coli 
EDTA    ethylenediaminetetraacetic acid 
Epo   erythropoietin 
EST     expressed sequence tag 
F-stat     F-statistic 
FACS    fluorescence-activated cell sorting 
FCS    bovine foetal calf serum 
FDR    false discovery rate 
FITC   fluoroscein  isothiocyanate 
FLT3    Fms-like kinase 3 
FPR     formyl peptide receptor  
G-CSF   granulocyte colony-stimulating factor 
G-CSFR G-CSF  receptor 
GAP   GTPase-activating  protein 
GH   growth  hormone 
GM    GM-CSF e.g. hGMRα  
GM-CSF granulocyte-macrophage colony-stimulating factor 
GMR   GM-CSF  receptor 
GMRα   GM-CSF receptor alpha subunit 
GO   gene  ontology 
h     human 
H0    null hypothesis  
  xvHa     alternate hypothesis  
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid 
HMG    high mobility group 
IAP    intracisternal-A particles  
IL-   interleukin 
IL-3Rα  IL-3 receptor alpha subunit 
IMDM   Iscove’s modified Dulbecco’s medium  
ITD   internal  tandem  duplications 
JAK   Janus  kinase 
JCML   juvenile chronic myelogenous leukaemia 
JMML   juvenile myelomonocytic leukemia 
kb     kilobase(s) 
kDa     kilo Dalton 
LB     Luria-Bertani 
LIF     leukaemia inhibitor factor 
Lowess   locally weighted linear regression 
m   murine 
M    mole(s) per litre 
M-CSF  macrophage colony-stimulating factor 
MAP kinase  mitogen-activated protein kinase 
MAPKK  MAP kinase kinase 
mL   millilitre(s) 
MDS   myelodysplastic  syndrome 
MPD     myeloproliferative disorder 
MPLV   myeloproliferative leukaemia retrovirus  
MOPS     3-(N-morpholino) propanesulphonic acid 
MQ   Milli-Q 
MuLV   murine leukaemia virus  
MW     molecular weight 
NF1   neurofibromatosis  type  1 
NIA    National Institute of Aging 
NPM   Nucleophosmin 
NS   Nucleostemin 
  xviNSCLC   non-small cell lung cancers  
NUMA1  nuclear mitotic apparatus protein 1 
OSM   oncostatin 
PAGE    polyacrylamide gel electrophoresis 
PBS     phosphate buffered saline 
PCR     polymerase chain reaction 
PE   phycoerythrin 
Pen/Strep   Penicillin G (5000 U/mL) and Streptomycin Sulphate (5000 mcg/mL) 
PI     phosphatidylinositol  
PI3K   phosphatidylinositol  3-kinase 
PKA     protein kinase A 
PLZF    promyelocytic leukaemia zinc finger 
PMCI    Peter MacCallum Cancer Institute 
PML     promyelocytic leukemia 
PMT   photo-multiplier  tube 
POD    PML oncogenic domains 
PV   polycythemia  vera 
R    receptor (e.g. IL-3R) 
RA    retinoic acid  
RAR    retinoic acid receptor 
RARE    retinoic acid response elements 
Rb     retinoblastoma 
rpm   revolutions  per  minute 
RSMC   rat aortic smooth-muscle cell 
RT     reverse transcription 
RTK     receptor tyrosine kinase 
RT-PCR   reverse transcription-polymerase chain reaction 
s     standard deviation 
s
2     variance 
SAGE   serial analysis of gene expresion 
SCF    stem cell factor 
SDS     sodium dodecyl sulphate 
SE     standard error 
SFFV    Friend spleen focus-forming virus  
  xviiSFK    Src family kinase 
siRNA   small interfering RNA 
SMA    Statistics for Microarray Analysis  
SSC    saline sodium citrate 
STAT   signal  transducer  and  activator of transcription 
t-stat     t test statistic 
TAE     Tris-Acetic acid-EDTA 
Taq   Thermus aquaticus 
TE   Tris-EDTA 
TEMED   N, N, N’, N’-tetramethylethane-1,2-diamine 
TGF     transforming growth factor 
TM   transmembrane 
Tpo   thrombopoietin 
Tris   tris[hydroxymethyl]aminomethane 
(2-amino-2-(hydroxmethyl)propane-1,3-diol) 
Tris-HCL tris(hydroxymethyl)aminomethane hydrochloride 
TGFβ    transforming growth factor-β 
U   units 
µL   microlitre(s) 
uPA    urokinase type plasminogen activator 
UV   ultraviolet 
V   volts 
% (v/v)  percentage volume per volume 
% (w/v)  percentage weight per volume 
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